Cerebral Circulation and Perfusion PDF

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Document Details

FriendlyTrust

Uploaded by FriendlyTrust

University of KwaZulu-Natal - Westville

Tags

cerebral circulation blood-brain barrier cerebrospinal fluid medical physiology

Summary

This document covers the cerebral circulation, Blood-Brain Barrier (BBB), and Cerebrospinal Fluid (CSF), including their composition, functions, and clinical applications. It details the components of the BBB, the challenges in drug delivery, and the role of CSF in brain protection. The document also describes hydrocephalus and lumbar puncture.

Full Transcript

**Cerebral Circulation and Perfusion** 1. **Cerebral Perfusion vs. Other Circulatory Loops** - The brain requires a **specialized circulation** due to its high metabolic activity (\~750 ml/min). - Cerebral circulation is mediated through the **Circle of Willis** and i...

**Cerebral Circulation and Perfusion** 1. **Cerebral Perfusion vs. Other Circulatory Loops** - The brain requires a **specialized circulation** due to its high metabolic activity (\~750 ml/min). - Cerebral circulation is mediated through the **Circle of Willis** and its branches. - Any interruption in blood flow can cause **ischemia**, leading to dire consequences. 2. **Blood-Brain Barrier (BBB)** - Protects the brain by regulating the entry of substances from the bloodstream into the brain tissue. - **Components of the BBB**: - **Tight junctions** between endothelial cells, involving proteins like **claudins** and **occludins**. - **Enhanced vesicular transport**, including both adsorptive and receptor-mediated transport. - **Astrocyte foot processes** surrounding the capillaries. - **Metabolic barrier** created by enzymes like **DOPA decarboxylase** and **MAO**. - Enhanced vesicular transport system (both adsorptive and receptor mediated) with a complex transcytosis process (A) - Specialized carrier mediated transport (highly specific) - **Challenges for Drug Delivery**: While essential for protection, the BBB complicates the delivery of therapeutic agents to the brain. - **Special Areas Without BBB**: Some regions, such as the **subfornical organ** and **median eminence**, lack the BBB to perform specific functions. - **Development**: The BBB is not fully developed at birth, impacting neonatal brain protection. - Blood chemistry is variable! eg NE from adrenal gland, bacteria, amino acids, etc. & these can all alter nerve function - Erhlick first described the unusual cerebral circulation → BBB. - **Cerebrospinal Fluid (CSF)** 1. **Composition and Role** - CSF is clear with a **specific gravity of 1005**, low in proteins and leucocytes, but contains ions like **Na+** and **K+**. - Provides **buoyancy** to the brain, reducing its effective weight to \~50g. - Acts as a cushion for mechanical protection and serves a role similar to the **lymphatic system**. - Secreted by the **choroid plexuses** at \~720 ml/day and is reabsorbed into the venous system via **arachnoid villi**. 2. **Ventricular System** - **CSF circulates** through the **ventricles** (lateral, third, fourth), the **subarachnoid space**, and the **spinal cord**. - The volume of CSF is approximately **150 ml**, with a pressure range of **70--180 mmCSF** (as measured by a manometer). - CSF circulation removes waste products, paralleling its role in infection detection (e.g., through **lumbar puncture** for CSF sampling). **Hydrocephalus** - **Etiology**: Occurs due to the imbalance between CSF secretion and absorption, leading to excess fluid in the brain. - Can be either **communicating** (CSF can still circulate) or **non-communicating** (blockage in the CSF flow). **Clinical Procedures** 1. **Lumbar Puncture**: - Performed between the **L3-L4** or **L4-L5** vertebrae. - Used to sample CSF, measure CSF pressure, or deliver drugs (**intrathecal injection**). - CSF usually accessed between L3-L4 or L4-L5 spinous processes **Key Points on BBB and Drug Administration** - The **BBB** prevents entry of neurotransmitters like **dopamine**. Thus, in treating Parkinson\'s disease, **L-DOPA** (a precursor) is administered along with **carbidopa** to inhibit DOPA decarboxylase outside the brain, ensuring dopamine production inside the brain.

Use Quizgecko on...
Browser
Browser